Loading...
A084650 logo

LabGenomics Co., Ltd.KOSDAQ:A084650 Stock Report

Market Cap ₩56.1b
Share Price
n/a
1Y-68.6%
7D8.5%
1D-7.7%
Portfolio Value
View

LabGenomics Co., Ltd.

KOSDAQ:A084650 Stock Report

Market Cap: ₩56.1b

LabGenomics (A084650) Stock Overview

Engages in the research and development of biotechnology products in South Korea. More details

A084650 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

A084650 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW491,406 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
491,406 investors already sharing narratives

LabGenomics Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for LabGenomics
Historical stock prices
Current Share Price₩756.00
52 Week High₩2,585.00
52 Week Low₩621.00
Beta-0.074
1 Month Change-29.81%
3 Month Change-40.00%
1 Year Change-68.63%
3 Year Change-82.80%
5 Year Change-83.74%
Change since IPO-36.34%

Recent News & Updates

Analysis Article Jan 28

Little Excitement Around LabGenomics Co., Ltd.'s (KOSDAQ:084650) Revenues

You may think that with a price-to-sales (or "P/S") ratio of 1.5x LabGenomics Co., Ltd. ( KOSDAQ:084650 ) is definitely...

Recent updates

Analysis Article Jan 28

Little Excitement Around LabGenomics Co., Ltd.'s (KOSDAQ:084650) Revenues

You may think that with a price-to-sales (or "P/S") ratio of 1.5x LabGenomics Co., Ltd. ( KOSDAQ:084650 ) is definitely...
Analysis Article Oct 28

LabGenomics Co., Ltd.'s (KOSDAQ:084650) Price Is Right But Growth Is Lacking

With a price-to-sales (or "P/S") ratio of 2.1x LabGenomics Co., Ltd. ( KOSDAQ:084650 ) may be sending very bullish...
Analysis Article May 19

Insufficient Growth At LabGenomics Co., Ltd. (KOSDAQ:084650) Hampers Share Price

LabGenomics Co., Ltd.'s ( KOSDAQ:084650 ) price-to-sales (or "P/S") ratio of 2.2x might make it look like a strong buy...
Analysis Article Apr 08

Is LabGenomics (KOSDAQ:084650) Using Debt In A Risky Way?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Jan 06

There's No Escaping LabGenomics Co., Ltd.'s (KOSDAQ:084650) Muted Revenues Despite A 46% Share Price Rise

LabGenomics Co., Ltd. ( KOSDAQ:084650 ) shareholders would be excited to see that the share price has had a great...
Analysis Article Nov 17

Not Many Are Piling Into LabGenomics Co., Ltd. (KOSDAQ:084650) Stock Yet As It Plummets 26%

Unfortunately for some shareholders, the LabGenomics Co., Ltd. ( KOSDAQ:084650 ) share price has dived 26% in the last...
Analysis Article Nov 08

Is LabGenomics (KOSDAQ:084650) Weighed On By Its Debt Load?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Sep 21

Slammed 29% LabGenomics Co., Ltd. (KOSDAQ:084650) Screens Well Here But There Might Be A Catch

LabGenomics Co., Ltd. ( KOSDAQ:084650 ) shares have retraced a considerable 29% in the last month, reversing a fair...
Analysis Article Aug 06

Market Might Still Lack Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650) Even After 35% Share Price Boost

LabGenomics Co., Ltd. ( KOSDAQ:084650 ) shares have had a really impressive month, gaining 35% after a shaky period...
Analysis Article Jul 27

Is LabGenomics (KOSDAQ:084650) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article Apr 09

Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)

LabGenomics Co., Ltd.'s ( KOSDAQ:084650 ) price-to-sales (or "P/S") ratio of 2.8x might make it look like a strong buy...
Analysis Article Mar 31

If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

A084650KR BiotechsKR Market
7D8.5%-5.3%-7.3%
1Y-68.6%-2.8%123.0%

Return vs Industry: A084650 underperformed the KR Biotechs industry which returned -2.8% over the past year.

Return vs Market: A084650 underperformed the KR Market which returned 121.9% over the past year.

Price Volatility

Is A084650's price volatile compared to industry and market?
A084650 volatility
A084650 Average Weekly Movement17.1%
Biotechs Industry Average Movement11.2%
Market Average Movement9.4%
10% most volatile stocks in KR Market16.5%
10% least volatile stocks in KR Market4.9%

Stable Share Price: A084650's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A084650's weekly volatility has increased from 10% to 17% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002105Sung Chinwww.labgenomics.co.kr

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

LabGenomics Co., Ltd. Fundamentals Summary

How do LabGenomics's earnings and revenue compare to its market cap?
A084650 fundamental statistics
Market cap₩56.13b
Earnings (TTM)-₩63.71b
Revenue (TTM)₩84.19b
0.7x
P/S Ratio
-0.9x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A084650 income statement (TTM)
Revenue₩84.19b
Cost of Revenue₩56.43b
Gross Profit₩27.76b
Other Expenses₩91.47b
Earnings-₩63.71b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-858.13
Gross Margin32.98%
Net Profit Margin-75.67%
Debt/Equity Ratio36.1%

How did A084650 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/12 05:43
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LabGenomics Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimHanwha Investment & Securities Co., Ltd.
Wan KuiM Securities
Kyung-Churl NohSK Securities Co., Ltd.